ARGOS THERAPEUTICS INC: 10-Q filed 2016-08-15
What ARGOS THERAPEUTICS INC reported in its quarterly report filed 2016-08-15 (fiscal Q2 2016): 30 published measures, 79 facts as tagged in accession 0001171843-16-011779.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-08-15
- Fiscal period
- fiscal Q2 2016
- Accession
- 0001171843-16-011779 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARGOS THERAPEUTICS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 66,435,111 | USD | |
| At 2015-12-31 | 31,037,699 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 4,261,617 | USD | |
| At 2015-12-31 | -28,201,435 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 34,830,164 | USD | |
| At 2015-12-31 | 6,163,144 | USD | |
| At 2015-06-30 | 22,991,967 | USD | |
| At 2014-12-31 | 37,223,590 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -12,606,245 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -25,426,433 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -19,604,818 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -37,151,033 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 5,635,239 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 5,010,684 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 488,643 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 635,072 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 107,391 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 286,162 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -304,385,140 | USD | |
| At 2015-12-31 | -278,958,707 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 0 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 29,145,088 | USD | |
| At 2015-12-31 | 22,306,384 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 2,497,254 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 1,766,853 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -12,065,020 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -24,395,591 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -18,886,801 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -35,846,213 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 37,279,003 | USD | |
| At 2015-12-31 | 8,720,295 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 543,462 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 1,034,655 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 725,522 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 1,320,437 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 17,876,918 | USD | |
| At 2015-12-31 | 8,162,813 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 5,135,238 | USD | |
| At 2015-12-31 | 2,907,683 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 12,553,663 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 25,030,663 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 18,994,192 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 36,132,375 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 9,164,184 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 18,666,160 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 16,084,834 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 30,851,816 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 32,031,452 | shares | |
| At 2015-12-31 | 21,641,509 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 308,744,563 | USD | |
| At 2015-12-31 | 250,873,875 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -129,837 | USD | |
| At 2015-12-31 | -138,245 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 31,300,000 | USD | |
| At 2015-12-31 | 32,400,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 38,412,373 | USD | |
| At 2015-12-31 | 31,150,719 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 9,267,285 | USD | |
| At 2015-12-31 | 8,844,335 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 11,020 | USD | |
| At 2015-12-31 | 11,020 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 3,831,736 | USD | |
| At 2015-12-31 | 3,676,846 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 1,247,696 | USD | |
| At 2015-12-31 | 740,173 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 3,389,479 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 6,364,503 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 2,909,358 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 5,280,559 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 237,996 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 439,738 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 181,530 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 347,962 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -541,225 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -1,030,842 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -718,017 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -1,304,820 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 378,776 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 2,058,051 | USD | 181 |
Inspect the source
- Entity
- ARGOS THERAPEUTICS INC / CIK 0001105533
- Captured
- SEC response SHA-256
07ee84a7b42518f1df0d6d45cc8782b7755c6cd7cd844b2cc13a94f0396ce00f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001105533.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))